FTC Urges 8th Circ. Not To Pause Insulin Pricing Case

By Matthew Perlman · March 14, 2025, 5:35 PM EDT

The Federal Trade Commission has urged the Eighth Circuit not to pause its in-house case accusing Caremark Rx, Express Scripts and OptumRx of artificially inflating insulin prices, telling the appeals court...

To view the full article, register now.

Documents

Case Information

Case Title

Express Scripts, Inc. et al v. Federal Trade Commission et al

Case Number

4:24-cv-01549

Court

Missouri Eastern

Nature of Suit

Other Statutory Actions

Date Filed

November 19, 2024


Case Title

Express Scripts, Inc., et al v. FTC, et al

Case Number

25-1383

Court

Appellate - 8th Circuit

Nature of Suit

3890 Other Statutory Actions

Date Filed

February 24, 2025